Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD) [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes BEAM-302 being studied for safety and efficacy in adults with Alpha-1 antitrypsin deficiency in a Phase 1/2 trial, and the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• BEAM-302

Snippet

Sponsor: Beam Therapeutics Inc. | Conditions: Alpha 1-Antitrypsin Deficiency | Phase 1, Phase 2 | Status: RECRUITING